RTSN (RTSN)

NASDAQ: RTSN · USD

$13.0

-0.52 (-3.9%)· Recorded snapshot

Market cap	108.3M
Net income (ttm)	-14.2M
EPS (ttm)	-$17.7
Shares out	8.3M
Volume	65,214

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -14.2M
EPS (ttm): -$17.7
Market cap: 108.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All RTSN indicators

Market & fundamental data

Available fields

120

Groups with data

Currency

USD

Showing 120 of 120 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0002002988
Country	United States
Country code	US
CUSIP number	76135H100
Earnings date	2026-11-12
Earnings time	amc
Employees	12
Enterprise value	$94.8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-10-09
Fiscal year end	December
Founded	2023
Industry	Biotechnology
IPO date	2026-10-09
Is primary listing	Yes
Is SPAC	No
ISIN number	US76135H1005
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$108.3M
Market cap category	Micro-Cap
Next earnings date	2026-11-12
Price	$13.00
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	RTSN
U.S. state	Virginia
Website	https://www.retensionpharmaceuticals.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-135.94%
P/B ratio	8.42x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Profit per employee	$-1.2M
ROCE	-112.15%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
EBIT	$-14.9M
EPS	$-17.67
Financing cash flow	$7.1M
Net cash flow	$-4.8M
Net income	$-14.2M
Operating cash flow minus SBC	$-12.3M
Operating income	$-14.9M
Stock-based compensation	$420,477

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$-18.48
Debt / equity	0
Long-term assets	$0
Long-term liabilities	$0
Net cash (debt)	$13.5M
Net cash / market cap	12.09%
Net debt / equity	-1.02
Piotroski F-Score	1
Shareholders' equity	$13.3M
Tangible book value	$-14.9M
Tangible book value per share	$-18.48
Total assets	$16.1M
Total cash	$13.5M
Total debt	$0
Total liabilities	$2.9M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	$16.1M
Current liabilities	$2.9M
Current ratio	5.61
Net working capital	$-241,139
Quick ratio	4.69
Working capital	$13.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.11%
Dividend yield	0%
Shareholder yield	-0.11%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	-3.85%
1W price change	-19.65%
1W total return	-19.65%
52-week high	$18.64
52-week high date	2026-10-19
52-week low	$9.66
52-week low date	2026-10-09
All-time high	$18.64
All-time high date	2026-10-19
All-time low	$9.66
All-time low date	2026-10-09
Average true range (ATR)	$2.12
Average volume	170.4K
Beta (1Y)	-17.05
Change from 52-week high	-30.26%
Change from 52-week low	34.58%
Change from all-time high	-30.26%
Change from all-time low	34.58%
Change from open	-4.48%
Day's gap	0.67%
Dollar volume	$847,782
High price	$13.61
Low price	$12.47
Monthly RSI	0
Open price	$13.61
Position in 52-week range	46.49%
Premarket change	4.14%
Premarket close	$13.52
Premarket price	$14.08
Premarket volume	137
Previous close	$13.52
Relative volume	0.38
Return from IPO open	34%
Return from IPO price	11.67%
RSI	0
Sharpe ratio	4.09
Sortino ratio	9.09
Volume	65.2K
Weekly RSI	0

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5.6M
Float percentage	66.71%
Shares change (QoQ)	0.13%
Shares change (YoY)	0.11%
Shares held by insiders	23.29%
Shares held by institutions	12.03%
Shares outstanding	8.3M

Deeper analysis on RTSN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this RTSN report

Is a complete RTSN research report available?

No complete published report is available for RTSN (RTSN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

RTSN (RTSN)

Price

Financial snapshot

Fair-value bridge

Latest news · RTSN

Valuation

Balance sheet

Trading

Next earnings

Sector percentile context

All RTSN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on RTSN

Frequently asked questions